three new ORAL drugs for multiple sclerosis...Ampyra, cladribine, and fingolimod
March 2010
Please see updated information from the FDA concerning Ampyra and the risk of seizures
These will be the first oral drugs approved for treating MS.
Ampyra (Am-PEER-ah, dalfampridine) will be available soon through specialty pharmacies...and costs over $13,000 a year.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote